Skip to content
PH-RO18

Hyperplastic and benign breast changes

How the terminal duct lobular unit responds to cyclical hormones, why cysts, hyperplasia with and without atypia, fibroadenoma and phyllodes tumour form, and what each means for later breast cancer risk.

  • Free preview
  • 5 steps · 8 questions
  • 3D normal anatomy

By the end, you can

  • Describe the terminal duct lobular unit, its luminal and myoepithelial cells, and how hormones change it through the cycle and life.
  • Explain how cyclical stimulation leads to fibrocystic change, and why it adds little or no cancer risk.
  • Distinguish proliferative changes without atypia from atypical ductal and lobular hyperplasia, and relate each to the risk of breast cancer.
  • Compare fibroadenoma and phyllodes tumour in origin, appearance and behaviour.
  • Relate the common findings (lumps, cyclical pain, nipple discharge, calcification) to the lesion that causes them.

What it is

Benign breast changes are non-cancerous alterations of the breast glands and their stroma. Pathologists sort the epithelial changes into three groups by the cancer risk they carry: non-proliferative (fibrocystic change), proliferative without atypia (usual ductal hyperplasia, sclerosing adenosis, papilloma, radial scar) and atypical hyperplasia (ductal or lobular). The fibroepithelial tumours, fibroadenoma and phyllodes tumour, arise from the stroma of the lobule.

6 types to tell apart
Non-proliferative (fibrocystic) change
Cysts, fibrosis and apocrine metaplasia; very common in the reproductive years and regarded as an exaggeration of normal cyclical change. It adds little or no cancer risk.
Proliferative change without atypia
More epithelial cells of a mixed, normal kind: usual ductal hyperplasia, sclerosing adenosis, intraductal papilloma and radial scar. A small rise in risk, in both breasts.
Atypical hyperplasia
A small, clonal population of uniform cells: atypical ductal hyperplasia (ADH) resembles low-grade ductal carcinoma in situ; atypical lobular hyperplasia (ALH) resembles lobular carcinoma in situ. A moderate rise in risk.
Fibroepithelial tumours
Fibroadenoma, the commonest benign breast tumour in young women, and the rarer phyllodes tumour (benign, borderline or malignant), in which the stroma grows into leaf-like fronds.
Inflammatory and reactive mimics
Fat necrosis after injury, duct ectasia (dilated large ducts with thick secretions and inflammation) and mastitis can all form a firm lump or draw in the skin or nipple, mimicking a carcinoma.
Gynaecomastia
Benign enlargement of the male breast ducts and stroma when the balance of oestrogen to androgen rises (puberty, older age, liver disease, some drugs); a rubbery disc under the nipple.

US spelling: tumours → tumors, tumour → tumor, oestrogen → estrogen.

Normal function

The terminal duct lobular unit

The breast is a modified sweat gland of 15 to 20 , set in fat and fibrous tissue. Each lobe drains through its own to the . Inside a lobe the ducts branch and end in terminal duct lobular units (TDLUs): a terminal duct and the cluster of small acini (ductules) of a lobule, surrounded by loose, hormone-responsive intralobular stroma. Denser fibrous stroma and fat lie between the lobules.

Two layers of cells line every duct and acinus. Inner luminal cells secrete milk, and some of them carry receptors for oestrogen and progesterone. Outer myoepithelial cells sit on the basement membrane and contract to squeeze milk out. Pathologists rely on this second layer: benign and in situ lesions keep it, invasive carcinoma loses it.

Hormones remodel the unit. Oestrogen lengthens and branches the ducts; progesterone adds acini. In each cycle the epithelium proliferates and the stroma swells after ovulation, then regresses, which is why breasts feel fuller before a period. Pregnancy brings full lobular development; after the menopause the lobules shrink and fat replaces them. Almost every benign and malignant breast lesion arises in the TDLU.

Point to it on the model
The two cell layers of the terminal duct lobular unitSchematic
FeatureLuminal cellMyoepithelial cell
PositionLines the lumenOuter layer, on the basement membrane
RoleSecretes milkContracts to expel milk (oxytocin)
Hormone receptorsSome cells carry oestrogen and progesterone receptorsUsually none
Typical stainsLuminal keratins, E-cadherinp63, smooth muscle myosin, basal keratins
In diseaseGives rise to hyperplasia, in situ and invasive carcinomaKept in benign and in situ lesions; absent around invasive carcinoma

Simplified. The stroma of the lobule is a third component: it gives rise to fibroadenoma and phyllodes tumour.